On The Internet! Take the Self Improvement Tour
Michael Mullan PhD
Michael Mullan Quick Facts
Dr. Michael Mullan is a leading specialist in the study of Alzheimer's Disease, a disease that causes suffering in some five million Americans. He is the President and CEO at Roskamp Institute, a non-profit organization dedicated to the research of neurodegenerative disorders and he is director at the Roskamp Memory Disorder Clinic. Through his leadership positions, he works towards his lifelong dream of discovering and safe drug therapies that are effective as well as new forms of treatments that are successful in helping people age in healthy ways. While studying and researching, he also finds time to teach and give lectures in professional and educational venues to share his discoveries with his colleagues.
Educational and Professional Credentials
A native of the United Kingdom, Dr. Michael Mullan is from the district of Farnborough in Kent. He went to London University to pursue medicine. He was awarded many prizes and recognitions at the university, including the Hoechst Elective Award that was given for studies in genetics in 1984. He earned his MBBS and then continued his studies by enrolling in the Royal College of Psychiatrists, also in the UK. While earning his MRCPsych degree, he won the Ethel Williams Scholarship of 1987 in recognition of his Alzheimer's postgraduate research. For his research in the clinical and the molecular genetics inherent in Familial Alzheimer's Disease, he accepted a post as a Research Registrar at Bethlem and Maudsley Special Health Authority in 1987. During the years 1988-1991, he continued studying the clinicogenetic correlates found in Familial Alzheimer's Disease and the techniques involved with molecular genetics. He received his PhD in Philosophy in 1993 for his studies in the field of molecular genetics from London University. The American Health Assistance Foundation chose him to participate in the 2nd International Conference of Alzheimer's Disease that was held in Canada. In 1991 he received a grant from the Mental Health Foundation for his work in how Alzheimer's Disease develops in cases involving late onset. Many other prestigious awards were bestowed on Dr. Mullan for his research into the connection between chromosome 19 and early onset of Alzheimer's. He also did extensive research into the genetics surrounding early onset of Alzheimer's as the co-principal investigator for the NIA. During his studies and after, he held a number of positions in medicine and psychogeriatrics as a registrar at Friern Hospital as well as the Royal Free Hospital.
About the Roskamp Institute
Based in Florida, the Roskamp Institute is an important non-profit organization that focuses its research into the causes and possible cures for neuropsychiatric diseases and neurodegenerative diseases. As the CEO and President of the Roskamp Institute, Dr. Michael Mullan develops therapy targets that help the understanding behind the etiology of Alzheimer's Disease. In addition, he was part of the team that uncovered a genetic error leading to high levels of beta-amyloid. This type of mutation is at the core of Alzheimer's Disease that was found in mice.
